[Peg-interferon or pegylated interferon].
Taeron
Corinne
C
D000998:Antiviral Agents / Q000627:therapeutic use*; D000075202:Contraindications; D016903:Drug Monitoring / Q000379:methods; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D010353:Patient Education as Topic / Q000379:methods; D018579:Patient Selection; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a